Chadi Tabaja,Mohamad Mdaihly,Charbel Noujaim et al.
Chadi Tabaja et al.
Over the last 2 decades, thermal-based catheter ablation has remained the mainstay treatment of cardiac arrhythmias. Although rare, thermal ablation can extend beyond the myocardium resulting in serious adverse events namely pulmonary vein ...
Charbel Noujaim,Chadi Tabaja,Oussama M Wazni et al.
Charbel Noujaim et al.
Pulsed field ablation (PFA) has emerged as a promising, nonthermal technique for arrhythmia ablation, leveraging high-voltage electrical fields to induce electroporation and create precise ablation lesions. Unlike traditional thermal method...
Moritz Nies,Jacob S Koruth
Moritz Nies
High-voltage electric fields can lead to increased permeability of cell membranes-a phenomenon called electropermeabilization. The mechanisms contributing to this effect are electroporation, membrane lipid peroxidation, oxidative stress, an...
Fengwei Zou,Luigi Di Biase
Fengwei Zou
The Infamous Duo [0.03%]
臭名昭著的二人组
Luigi Di Biase,Emily P Zeitler
Luigi Di Biase
Atrial Fibrillation Incidence, Outcomes, and Management in Patients with Left Ventricular Assist Devices and Orthotopic Heart Transplants [0.03%]
左心室辅助装置和心脏移植患者的房颤发病率、预后及治疗状况
Sahitya Allam,Alexander Hajduczok,Philipp Sommer et al.
Sahitya Allam et al.
This article explores the existing knowledge regarding atrial fibrillation (AF) incidence, outcomes, and management in left ventricular assist device and orthotopic heart transplant patients as well as emerging technologies such as catheter...
Sebastian E Beyer,Christian Sohns,Philipp Sommer
Sebastian E Beyer
End-stage heart failure (HF) accounts for 1% to 10% of all HF cases. It is frequently associated with coexistent atrial fibrillation due in part to structural changes related to altered hemodynamics, increased wall stress, and neurohormonal...
Atrioventricular Nodal Ablation and Pacing in Refractory Atrial Fibrillation and Heart Failure [0.03%]
难治性房颤和心力衰竭的房室结消融及起搏治疗
Rong Bai,Caijie Shen,Roderick Tung
Rong Bai
Atrioventricular nodal ablation (AVNA) represents a critical intervention in the management of refractory atrial fibrillation (AF) and heart failure (HF). When combined with biventricular pacing or conduction system pacing, particularly His...
Atrial Fibrillation Management with Guideline-Directed Medical Therapy and Comorbidity Treatment in Heart Failure Patients [0.03%]
心力衰竭患者的指南指导药物治疗和合并症治疗下的房颤管理
Alvise Del Monte,Andrea Sarkozy,Frederik H Verbrugge
Alvise Del Monte
Atrial myopathy is the underlying pathophysiological substrate of atrial fibrillation and contributes to the risk of heart failure as well. Atrial myopathy is caused by classic risk factors such as obesity, inflammation, diabetes, hypertens...
Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction [0.03%]
射血分数保留的心衰患者的房颤消融治疗
Vincenzo Mirco La Fazia,Nicola Pierucci,Sanghamitra Mohanty et al.
Vincenzo Mirco La Fazia et al.
Catheter ablation (CA) for atrial fibrillation (AF) in patients with heart failure with preserved ejection fraction (HFpEF) addresses the significant overlap of these conditions, often found in patients with comorbidities such as obesity, d...